The Royal Blackburn Teaching Hospital is an acute District General Hospital in Blackburn, Lancashire operated by the East Lancashire Hospitals NHS Trust.

During the past decade, Royal Blackburn Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 5 clinical trials were completed, i.e. on average, 21.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Blackburn Hospital" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Institute of Cancer Research, United Kingdom" with 4 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "NHS National Waiting Times Centre Board" with 2 trials sponsored and "Velindre NHS Trust" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Blackburn Hospital" #1 collaborator was "University of Glasgow" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Academic Medical Organization of Southwestern Ontario" with 1 trials as a collaborator, "AdventHealth" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Royal Blackburn Hospital" are "Breast Cancer" (2 trials), "Breast Cancer Female" (2 trials), "Coronary Artery Disease" (2 trials), "Diabetes" (2 trials) and "Fallopian Tube Cancer" (2 trials). Many other conditions were trialed in "Royal Blackburn Hospital" in a lesser frequency.

Most popular intervention types in "Royal Blackburn Hospital" are "Drug" (19 trials), "Other" (9 trials), "Device" (6 trials), "Procedure" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atezolizumab" (2 trials), "fluorouracil" (2 trials), "quality-of-life assessment" (2 trials) and "questionnaire administration" (2 trials). Other intervention names were less common.

The vast majority of trials in "Royal Blackburn Hospital" are 30 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Blackburn Hospital". undefined are not yet recruiting, 9 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Royal Blackburn Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Blackburn Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".